Clinical Research Directory

Browse clinical research sites, groups, and studies.

Sites Groups Studies

Back to Studies

COMPLETED

NCT07033533

PHASE1/PHASE2

Allopurinol and Pathogenesis of Cirrhosis

Sponsor: Tanta University

View on ClinicalTrials.gov

Summary

Hepatic decompensation is a common healthcare issue . This study was conducted to investigate how allopurinol can interfere with the pathological mechanisms of HD.

Official title: Allopurinol Interferes With the Pathological Mechanisms of Hepatic Decompensation

Key Details

Gender

All

Age Range

18 Years - 75 Years

Study Type

INTERVENTIONAL

Enrollment

100

Start Date

2023-06-01

Completion Date

2024-03-01

Last Updated

2026-09-11

Healthy Volunteers

Conditions

Cirrhoses, Liver

Interventions

DRUG

Allopurinol Tablet

allopurinol 300

DRUG

Placebo

placebo tablet

Locations (1)

Tanta University

Tanta, Egypt